Skip to main content
. 2022 Feb 17;88(6):2700–2717. doi: 10.1111/bcp.15242

FIGURE 3.

FIGURE 3

Age distribution of 3 populations providing information on the safety of simvastatin: the participants in clinical trials for simvastatin approval in France (n = 2221), a random sample of reimbursed simvastatin prescriptions in France (n = 500) and spontaneous report cases for 20 mg simvastatin in the French Pharmacovigilance database (n = 112; reproduced with permission from Martin et al., 2004) 102